跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,492 条关于
“Pemi”
全部
1,492
临床试验
1,404
药物
43
机构
4
资讯
41
14天前
Pemi Launches Women's Daily Supplement Routine Built Specifically for Perimenopause
2年前
Pemivibart Guidelines Updated for COVID-19 Preexposure Prophylaxis in Immunocompromised Patients
去年
Invivyd's Pemgarda Shows Continued Neutralizing Activity Against SARS-CoV-2 Variant XEC
去年
FDA Approves Pemigatinib for Rare FGFR1-Rearranged Myeloid/Lymphoid Neoplasms Following Stanford-Led Phase II Trial
去年
Invivyd's Pemivibart Shows 76% Protection Rate Against COVID-19 in Phase 3 Trial
去年
Invivyd's PEMGARDA Shows 84% COVID-19 Prevention Efficacy in Landmark Phase 3 Trial
去年
Invivyd's Pemivibart Shows Promising Clinical Efficacy in COVID-19 Prevention
6个月前
Invivyd Publishes Variant-Agnostic COVID-19 Protection Model for Monoclonal Antibody Pemivibart
去年
Invivyd's Pemivibart Shows Long-Term COVID-19 Protection in CANOPY Trial
2个月前
FGFR Inhibitor Cancer Drugs Linked to Dry Eye and Corneal Damage in FAERS Analysis
第 1 页,共 5 页
上一页
下一页